J

Polatuzumab Vedotin in 1L DLBCL: Perspectives on the POLARIX Trial

By Juan Pablo Alderuccio 2 Videos
216 views
July 8, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
22:11
SOHO Brazil 2024

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

Feat. A. Zelenetz
22:09
Scripps Health

New Updates in Frontline DLBCL

Feat. L. Nastoupil
27:47
Indy Hematology Review

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Feat. S. Smith
35:27
Louisville Hematology Highlights

Updates on Management of DLBCL

Feat. J. Leonard
04:04
Wojciech Jurczak

Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial

10:04
Tara Graff

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

08:01
Georg Lenz

Treatment Landscape in 1L DLBCL: Polatuzumab Vedotin as SoC

30:07
Dipenkumar Modi

Current Management of DLBCL From Frontline to Relapsed Disease

35:24
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: Aggressive B-Cell Lymphomas

Feat. G. Nowakowski
34:36
MyCancerHaven

Frontline DLBCL Treatment Approaches

Feat. R. Vij, H. Cherng
16:34
Jennifer Amengual

Top 5 Lymphoma Abstracts From ASH

29:26
Massachusetts General Hospital Cancer Center

Practice-Changing Updates in DLBCL and HL

Feat. J. Erika Haydu
15:26
Moffitt Cancer Center

R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?

Feat. A. Lazaryan
40:38
UChicago Medicine

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

Feat. G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu
62:02
UChicago Medicine

New Treatment Strategies in DLBCL

Feat. L. Sehn
16:03
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: The New Algorithm for 2L LBCL

Feat. J. Westin
14:47
UChicago Medicine

Bispecifics for LBCL: Guidance for Management of Toxicities in the C…

Feat. J. Crombie
28:11
Total Health

Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL…

Feat. M. Rotta
17:21
Daniel Addison

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…